Arterial Spin-Labeling Parameters Influence Signal Variability and Estimated Regional Relative Cerebral Blood Flow in Normal Aging and Mild Cognitive Impairment: FAIR versus PICORE Techniques

REFERENCES

1. 1.↵
   2. Roberts DA,
   3. Detre JA,
   4. Bolinger L, et al

   . Quantitative magnetic resonance imaging of human brain perfusion at 1.5 T using steady-state inversion of arterial water. Proc Natl Acad Sci U S A 1994;91:33–37

   Abstract/FREE Full Text
2. 2.↵
   2. Yoshiura T,
   3. Hiwatashi A,
   4. Noguchi T, et al

   . Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer's disease. Eur Radiol 2009;19:819–25
3. 3.↵
   2. Yoshiura T,
   3. Hiwatashi A,
   4. Yamashita K, et al

   . Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spin-labeling in patients with Alzheimer disease. AJNR Am J Neuroradiol 2009;30:1388–93

   Abstract/FREE Full Text
4. 4.↵
   2. Dai W,
   3. Lopez OL,
   4. Carmichael OT, et al

   . Mild cognitive impairment and Alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 2009;250:856–66

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Binnewijzend MA,
   3. Kuijer JP,
   4. Benedictus MR, et al

   . Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology 2013;267:221–30

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Wolk DA,
   3. Detre JA

   . Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions. Curr Opin Neurol 2012;25:421–48

   CrossRefPubMed
7. 7.↵
   2. Xekardaki A,
   3. Rodriguez C,
   4. Montandon ML, et al

   . Arterial spin labeling may contribute to the prediction of cognitive deterioration in healthy elderly individuals. Radiology 2015;274:490–99

   CrossRefPubMed
8. 8.↵
   2. Bozoki AC,
   3. Korolev IO,
   4. Davis NC, et al

   . Disruption of limbic white matter pathways in mild cognitive impairment and Alzheimer's disease: a DTI/FDG-PET study. Hum Brain Mapp 2012;33:1792–802

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Pagani M,
   3. Dessi B,
   4. Morbelli S, et al

   . MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings. Curr Alzheimer Res 2010;7:287–94

   CrossRefPubMed
10. 10.↵
    2. Herholz K,
    3. Salmon E,
    4. Perani D, et al

    . Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002;17:302–16

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Du AT,
    3. Jahng GH,
    4. Hayasaka S, et al

    . Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology 2006;67:1215–20

    CrossRefPubMed
12. 12.↵
    2. Buxton RB,
    3. Frank LR

    . A model for the coupling between cerebral blood flow and oxygen metabolism during neural stimulation. J Cereb Blood Flow Metab 1997;17:64–72

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Aubert A,
    3. Costalat R

    . A model of the coupling between brain electrical activity, metabolism, and hemodynamics: application to the interpretation of functional neuroimaging. Neuroimage 2002;17:1162–81

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Kim SG

    . Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping. Magn Reson Med 1995;34:293–301

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Wong EC,
    3. Buxton RB,
    4. Frank LR

    . Implementation of quantitative perfusion imaging techniques for functional brain mapping using pulsed arterial spin labeling. NMR Biomed 1997;10:237–49

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Alsop DC,
    3. Detre JA,
    4. Golay X, et al

    . Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 2014 Apr 8. [Epub ahead of print]
17. 17.↵
    2. Folstein MF,
    3. Folstein SE,
    4. McHugh PR

    . “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Luh WM,
    3. Wong EC,
    4. Bandettini PA, et al

    . QUIPSS II with thin-slice TI1 periodic saturation: a method for improving accuracy of quantitative perfusion imaging using pulsed arterial spin labeling. Magn Reson Med 1999;41:1246–54

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Wang J,
    3. Licht DJ,
    4. Jahng GH, et al

    . Pediatric perfusion imaging using pulsed arterial spin labeling. J Magn Reson Imaging 2003;18:404–13

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Fazekas F,
    3. Chawluk JB,
    4. Alavi A, et al

    . MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351–56

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Smith SM,
    3. Nichols TE

    . Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009;44:83–98

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Heijtel DF,
    3. Mutsaerts HJ,
    4. Bakker E, et al

    . Accuracy and precision of pseudo-continuous arterial spin labeling perfusion during baseline and hypercapnia: a head-to-head comparison with (1)(5)O H(2)O positron emission tomography. Neuroimage 2014;92:182–92

    CrossRefPubMed
23. 23.↵
    2. Bokkers RP,
    3. Bremmer JP,
    4. van Berckel BN, et al

    . Arterial spin labeling perfusion MRI at multiple delay times: a correlative study with H(2)(15)O positron emission tomography in patients with symptomatic carotid artery occlusion. J Cereb Blood Flow Metab 2010;30:222–29

    CrossRefPubMed
24. 24.↵
    2. Zhang K,
    3. Herzog H,
    4. Mauler J, et al

    . Comparison of cerebral blood flow acquired by simultaneous [15O]water positron emission tomography and arterial spin labeling magnetic resonance imaging. J Cereb Blood Flow Metab 2014;34:1373–80

    CrossRefPubMed
25. 25.↵
    2. Stegger L,
    3. Martirosian P,
    4. Schwenzer N, et al

    . Simultaneous PET/MR imaging of the brain: feasibility of cerebral blood flow measurements with FAIR-TrueFISP arterial spin labeling MRI. Acta Radiol 2012;53:1066–72

    Abstract/FREE Full Text
26. 26.↵
    2. Kilroy E,
    3. Apostolova L,
    4. Liu C, et al

    . Reliability of two-dimensional and three-dimensional pseudo-continuous arterial spin labeling perfusion MRI in elderly populations: comparison with 15O-water positron emission tomography. J Magn Reson Imaging 2014;39:931–39

    CrossRefPubMed
27. 27.↵
    2. Qiu M,
    3. Paul Maguire R,
    4. Arora J, et al

    . Arterial transit time effects in pulsed arterial spin labeling CBF mapping: insight from a PET and MR study in normal human subjects. Magn Reson Med 2010;63:374–84

    CrossRefPubMed
28. 28.↵
    2. Wang Y,
    3. Saykin AJ,
    4. Pfeuffer J, et al

    . Regional reproducibility of pulsed arterial spin labeling perfusion imaging at 3T. Neuroimage 2011;54:1188–95

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Hendrikse J,
    3. Petersen ET,
    4. Chng SM, et al

    . Distribution of cerebral blood flow in the nucleus caudatus, nucleus lentiformis, and thalamus: a study of territorial arterial spin-labeling MR imaging. Radiology 2010;254:867–75

    CrossRefPubMed
30. 30.↵
    2. Hartkamp NS,
    3. Petersen ET,
    4. De Vis JB, et al

    . Mapping of cerebral perfusion territories using territorial arterial spin labeling: techniques and clinical application. NMR Biomed 2013;26:901–12

    CrossRefPubMed
31. 31.↵
    2. Fox NC,
    3. Warrington EK,
    4. Freeborough PA, et al

    . Presymptomatic hippocampal atrophy in Alzheimer's disease: a longitudinal MRI study. Brain 1996;119:2001–07

    Abstract/FREE Full Text